Clinical validation of NGS technology for HLA: An early adopter’s perspective
- 1 October 2016
- journal article
- review article
- Published by Elsevier BV in Human Immunology
- Vol. 77 (10), 820-823
- https://doi.org/10.1016/j.humimm.2016.06.014
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen TypingThe Journal of Molecular Diagnostics, 2016
- Modern approaches to HLA-haploidentical blood or marrow transplantationNature Reviews Clinical Oncology, 2015
- Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencingBMC Genomics, 2015
- Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDsFrontiers in Immunology, 2014
- Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencingBMC Genomics, 2014
- Phase-defined complete sequencing of the HLA genes by next-generation sequencingBMC Genomics, 2013
- Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnosticsBMC Genomics, 2013
- HLA DNA typing: past, present, and futureTissue Antigens, 2012
- A multi‐site study using high‐resolution HLA genotyping by next generation sequencingTissue Antigens, 2011
- The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniquesJournal of Clinical Pathology, 2010